• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.87% Nasdaq Up 0.34%

    Northwest Biotherapeutics, Inc. (NWBO)

    -NasdaqCM
    5.78 Up 0.04(0.70%) 4:00PM EST
    |After Hours : 5.78 0.00 (0.00%) 4:35PM EST
    Add to Portfolio
    Prev Close:5.74
    Open:5.71
    Bid:N/A
    Ask:19.33 x 300
    1y Target Est:5.00
    Beta:2.44
    Next Earnings Date:N/A
    Day's Range:5.61 - 5.88
    52wk Range:3.52 - 10.64
    Volume:430,791
    Avg Vol (3m):522,791
    Market Cap:359.62M
    P/E (ttm):N/A
    EPS (ttm):-2.09
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NWBO

    Comparison

    Symbol% ChgMkt Cap
    NWBOUp 0.70%359.62M
    AGENDown 1.00%247.60M
    DNDN 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):613.63
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Jun-14) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Northwest Biotherapeutics, Inc., a development stage biotechnology company, discovers and develops immunotherapy products to treat cancers in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback